BBAR Q4 2025 Earnings Earnings Beat Estimates Despite Stock Decline Protara Therapeutics Q1 2026 Earnings EPS Beats Estimates Amid Continued Pipeline Progress ABEV Q1 2026 Earnings EPS Misses Estimates as Cost Pressures Weigh AMP Q1 2026 Earnings EPS Beats Estimates by 923 as Wealth Management Segment Drives Results PRH Q1 2026 Earnings EPS Surges 154 Above Estimates Positive Market Response NICE Q1 2026 Earnings EPS Beat Amid Mixed Market Sentiment